Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by Analysis Of Fibrin Clot Properties And Thrombin Generation

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Completed1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT07275476Recruiting

Pregnancy and Fibrin Clot Properties

NCT02231398CompletedPrimary

nuMoM2b Heart Health Study

Showing all 2 trials

Research Network

Common Treatments

  • Analysis Of Fibrin Clot Properties And Thrombin Generation1

Active Sponsors

  • Jagiellonian University1
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
  • National Heart, Lung, and Blood Institute (NHLBI)1
  • RTI International1

Top Investigators

Related Conditions

  • Pregnancy1
  • Fibrin Blood Clot1
  • Breathingrelated Sleep Disorder1

Activity Timeline